STING1 and graft versus host disease: Together, our data suggest that activation of the RIG/MAVS and STING pathways, either through endogenous or applied ligands (IFN-stimulatory DNA, 3pRNA), may be essential for protection of gut epithelial integrity after TBI or chemotherapy and for the prevention of GVHD after allo-HSCT.